Search results
How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
Zacks· 4 days agoFree Report) closed the last trading session at $5.16, gaining 3.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
‘Not worth it to lie to the public’: AG seeks to take legal action against fossil fuel companies
WOOD via Yahoo News· 24 hours agoMichigan Attorney General Dana Nessel says her office will be seeking proposals from attorneys and...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript May 7, 2024 Madrigal ...
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Motley Fool via Yahoo Finance· 6 days agoUnfortunately...earnings outlook for 2024. That's an extremely high-earnings multiple for an...
‘I wonder if he’s on commission’: A psychiatrist online prescribed me Prozac, punched the air in...
MarketWatch via Yahoo Finance· 3 days ago“I processed a $50 copay, and attended my appointment with the psychiatrist. It went fast, and every...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 1 day agoWhile the telecom industry isn't immune to disruption, AT&T's proactive measures have so far kept such threats at bay...potentially potent value and...
Couple ‘fear for their lives’ after being blocked from felling limb-shedding tree
The Telegraph via Yahoo News· 3 days agoA couple claim they fear for their lives after a limb fell from an 80ft beech tree at the bottom of...
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 4 days agoIt's almost impossible for a company to grow its earnings without growing its revenue for long...
Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 4 days agoThe consensus price target hints at a 38.7% upside potential for Tarsus Pharmaceuticals (TARS)....
Michael Sachs
The National Law Review· 1 day agoMichael Sachs is a Partner with In-House Counsel Recruiting, based in Chicago. Over the years, Mike has spearheaded critical searches in numerous industries, including healthcare, energy, financial ...
